This situation has concluded
It was preserved as a record on July 27; the timeline below shows how it unfolded, with sources. Get the briefing to follow the top situations still developing: three emails a week, sourced and in order.
Unsubscribe anytime.
[SITUATION] · [QUIET] · [POLITICS]
31 clusters · 208 sources · 68 days · First seen · Last updated
U.S. legal battles over mifepristone access
Overview
The fight over mifepristone has continued into late June. The FDA told senators and House Appropriations Committee members that its six‑month safety review of the abortion pill will be completed by September. Lawmakers and pro‑life groups see the review as an opportunity to reinstate the pre‑2021 in‑person dispensing rule that the Biden administration removed, while the agency notes the review is routine and does not yet indicate any change to current policy.
The review follows a July 2026 Fifth Circuit decision that reinstated a Louisiana‑style block on mail‑order distribution, and a series of state laws tightening remote prescribing. The Supreme Court has repeatedly stayed lower‑court orders, keeping the mail‑order and telehealth framework in place while litigation proceeds. A Louisiana woman has sued the FDA, alleging coercion by her boyfriend to take the medication, adding a personal‑injunction angle to the national debate.
If the FDA concludes the medication is unsafe, it could restore the three‑visit, physician‑only requirement that existed before 2021. The outcome will shape the next phase of the legal and regulatory contest over abortion access across the United States.
Timeline
-
[HEALTH] 2 sourcesFDA to finish mifepristone safety review by September
The FDA expects to finish its mifepristone safety review by September, amid conservative calls to roll back mail‑order abortion rules; a pending decision could restore in‑person prescribing.
-
[HEALTH] 2 sourcesFDA urged by pro‑life doctors to restore in‑person abortion pill rule
Pro‑life doctors ask FDA's acting commissioner to reinstate in‑person dispensing of mifepristone, citing high complication rates and urging a safety review.
-
[POLITICS] 2 sourcesMissouri Lawmakers Confront AI Data Center Impacts and Abortion Law Overhaul
Missouri Rep. Don Mayhew calls for a special session on AI data center regulation, while Judge Jerri Zhang strikes down 40 abortion restrictions, sparking political backlash and an upcoming ballot measure.
-
[POLITICS] 2 sourcesMissouri judge nullifies state abortion restrictions
Missouri judge Jerri Zhang invalidated the state’s total abortion ban and related restrictions, citing the 2024 Amendment 3 constitutional guarantee of reproductive freedom; the decision restores abortion care,
-
[POLITICS] 4 sourcesMissouri Judge Strikes Down State Abortion Laws
Missouri judge voids 40 abortion restrictions, citing conflict with a voter‑approved amendment; officials plan appeals and a November ballot initiative looms.
-
[POLITICS] 5 sourcesMissouri Judge Strikes Down Abortion Restrictions, Restoring Medication Abortions
Missouri judge invalidates most abortion restrictions, allowing medication abortions and prompting a state appeal.
-
[POLITICS] 2 sourcesOhio doctors oppose 24‑hour abortion waiting period bill
Ohio physicians oppose House Bill 347, which would force a 24‑hour abortion waiting period, citing discrimination and unnecessary barriers; the bill faces legal challenges and a legislative deadline.
-
[POLITICS] 2 sourcesOhio doctors oppose 24‑hour abortion waiting period as study finds women lack pill‑use information
Ohio doctors criticize a 24‑hour abortion waiting‑period bill, while a study shows many women feel uninformed about mifepristone risks and side effects.
-
[HEALTH] 3 sourcesU.S. FDA Initiates Safety Review of Abortion Pill Mifepristone
The FDA has launched a six‑month safety review of the abortion pill mifepristone, examining medical records amid political and legal disputes over its telehealth distribution.
-
[HEALTH] 5 sourcesFDA launches safety review of mifepristone abortion pill
The FDA has started a retrospective safety study of the abortion pill mifepristone, which could tighten telehealth and mail‑order rules.
-
[POLITICS] 3 sourcesUS Supreme Court faces landmark cases on birthright citizenship, agency firings and immigration
The US Supreme Court will decide on crucial cases affecting birthright citizenship, TPS for Syrians and Haitians, asylum‑arrival rules, and presidential authority to fire independent agency officials.
-
[POLITICS] 6 sourcesSupreme Court to decide key cases on citizenship, guns and transgender athletes in June
The Supreme Court will rule in June on cases covering birthright citizenship, gun rights, transgender athletes, and presidential power over agencies, among other high‑profile issues.
-
[POLITICS] 2 sourcesUS Supreme Court Review Threatens Mail‑Order Access to Abortion Pill mifepristone
A 5th Circuit ruling ends mail‑order mifepristone distribution; Danco seeks a Supreme Court stay, risking nationwide loss of remote abortion access while safety remains unchanged.
-
[POLITICS] 6 sourcesU.S. Supreme Court Temporarily Preserves Mail‑Order Abortion Pill Access as States Enact New Restrictions
Supreme Court temporarily preserves mail‑order mifepristone access as Oklahoma and Iowa tighten abortion‑pill restrictions.
-
[POLITICS] 3 sourcesU.S. Supreme Court Halts Nationwide Ban on Abortion Pill
The US Supreme Court temporarily blocked a 5th Circuit order, preserving nationwide mail and telehealth access to the abortion pill mifepristone.
-
[POLITICS] 3 sourcesTrump administration launches push to raise U.S. birth rate
Trump’s MAFA plan cuts fertility drug costs and spurs a love‑song playlist to boost US births.
-
[POLITICS] 2 sourcesVatican report and US Supreme Court ruling underscore conversion therapy controversy
Vatican report decries conversion‑therapy harm as US Supreme Court narrows Colorado ban, heightening religion‑LGBTQ tension.
-
[POLITICS] 2 sourcesSupreme Court Review Sought for Rocklin School's Parental Notification Rule
Amicus brief urges Supreme Court to overturn California board's block of a school parental‑notification rule on gender accommodations.
-
[POLITICS] 51 sourcesUS Supreme Court blocks limits on mail‑order abortion pill, keeping telehealth access alive
Supreme Court halts a ruling that would stop mail‑order and telehealth access to the abortion pill mifepristone, preserving nationwide availability amid a Louis
-
[POLITICS] 2 sourcesU.S. Courts grapple with religious freedom in schools
U.S. courts address religious freedom disputes in schools, from a coach’s prayer to parents’ claims over transgender classmates.
-
[POLITICS] 2 sourcesReligious Liberty Commission hearing raises US faith‑based health‑care concerns
DOJ’s Religious Liberty Commission hearing spotlights US faith‑based health‑care disputes and church‑state separation debates.
-
[POLITICS] 45 sourcesSupreme Court extends mail access to abortion pill mifepristone
Supreme Court blocks Louisiana’s effort to halt mail delivery of abortion pill mifepristone, extending access temporarily.
-
[POLITICS] 2 sourcesTrump Administration Unveils IVF Fertility Benefits Rule and Drug Discount Site
Trump proposes a new employer‑offered IVF benefit rule and launches TrumpRx for discounted fertility drugs to address the U.S. fertility crisis.
-
[POLITICS] 31 sourcesSupreme Court Strikes Down Colorado Conversion‑Therapy Ban, Prompting Legislative Rewrite
Supreme Court nullified Colorado's conversion‑therapy ban; the state passed a revised, viewpoint‑neutral law to protect LGBTQ youth.
-
[POLITICS] 2 sourcesTrump administration launches Moms.gov site highlighting pro‑life pregnancy centers and fertility agenda
Trump’s new Moms.gov site lists over 2,750 pregnancy centers and, amid a pronatalist push, proposes employer IVF coverage while HHS cites a disputed fertility‑c
-
[POLITICS] 4 sourcesWashington AG Nick Brown urges Supreme Court to block mifepristone restrictions
Washington AG Nick Brown and a 22‑state coalition urged the Supreme Court to block a Fifth Circuit order reinstating in‑person mifepristone dispensing; the high
-
[POLITICS] 2 sourcesPresident Trump discusses US baby fertility decline and vaccine overload
Trump and Dr. Oz warn of US baby decline and vaccine overload, citing low fertility and concerns over mandatory shots.
-
[POLITICS] 2 sourcesU.S. Appeals Court Blocks Federal Abortion‑Pill Policy Amid Campus Access Debate
U.S. court blocks federal mifepristone policy as universities plan to offer the pill, fueling abortion‑access controversy.
-
[POLITICS] 33 sourcesUS Supreme Court Tackles Abortion‑Pill Docket and Voting‑Rights Map Disputes
Supreme Court hears a request to pause mifepristone rules, Gorsuch warns about leaks, and the Court limits Voting Rights Act map challenges.
-
[POLITICS] 4 sourcesSupreme Court rules for crisis pregnancy center in First Amendment challenge to donor-list probe
US Supreme Court backs faith-based crisis pregnancy center in First Amendment challenge to donor-list probe.
-
[POLITICS] 4 sourcesSupreme Court to hear Colorado Catholic preschool LGBTQ admission case
Colorado Catholic preschools challenge LGBTQ-admission rules tied to state funding as the Supreme Court takes up a religious freedom case.
Sources
4jewish.com · 6abc.com · ABC News · abc57.com · abovethelaw · academyofideas.com · alternet · americafirstreport.com · archyde.com · areanewsgroup.com · arktimes · baltimorefishbowl.com · baytoday.ca · bjconline.org · boston · boston.cbslocal.com · breitbart.com · brusselsmorning.com · business-panorama · careforth.com · catholicnews · catholicreview · CBSNews.com · centralmaine.com · chbcnews · christianitydaily.com · cinebuzz.com.br · citybeat.com · cmjornal.pt · cmjornal.xl.pt · CNBC · collive.com · conservativeangle.com · courthousenews · crooksandliars.com · cwfa.org · dailyMail.co.uk · dailynewsupdate.net · danamadeit.com · davisvanguard.org · disboards.com · dnyuz.com · drrichswier.com · drudge.com · duderanch.org · economix · econoTimes.com · econotimes.com